| # | Drug | Count |
|---|---|---|
| 0 | ZIDOVUDINE | 20 |
| 1 | LAMIVUDINE | 6 |
| 2 | NEVIRAPINE | 5 |
| 3 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 4 |
| 4 | LAMIVUDINE ORAL | 4 |
| 5 | TENOFOVIR DISOPROXIL FUMARATE | 3 |
| 6 | ABACAVIR SULFATE | 2 |
| 7 | IBALIZUMAB | 2 |
| 8 | LOPINAVIR AND RITONAVIR | 2 |
| 9 | METHADONE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBALIZUMAB | 2 | 0.0037 |
| 1 | ZIDOVUDINE | 20 | 0.0019 |
| 2 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 1 | 0.0006 |
| 3 | NEVIRAPINE | 5 | 0.0006 |
| 4 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0004 |
| 5 | LAMIVUDINE | 6 | 0.0002 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 2 | 0.0002 |
| 7 | ETRAVIRINE | 1 | 0.0002 |
| 8 | ABACAVIR SULFATE | 2 | 0.0002 |
| 9 | RALTEGRAVIR | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD4-directed Blocking Antibody [EPC] | 2 | 0.0037 |
| 1 | Sulfonamide Antibacterial [EPC] | 2 | 0.0005 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0002 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 27 | 0.0002 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0002 |
| 5 | Protease Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 3 | 0.0000 |